Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2021, 3(6); doi: 10.25236/FMSR.2021.030601.

Differential gene expression in B lymphocyte immune process induced by COVID-19 infection

Author(s)

Kehan Lin1, Hengxi Liu2, Junying Li3, Chenhao Shou4, Yihan Xia5, Ming Chu6, Xi Chen7

Corresponding Author:
Ming Chu
Affiliation(s)

1Nanjing Medical University, Nanjing, Jiangsu, China

2University of Washington--Seattle, Seattle, WA, United States

3The Barstow School-Ningbo Campus, Ningbo, Zhejiang, China

4Hangzhou Foreign Languages School, Hangzhou, Zhejiang, China

5Shanghai Pinghe Bilingual School, Shanghai, China

6,7Department of Immunology, School of Basic Medical Sciences, Peking University. NHC Key Laboratory of Medical Immunology (Peking University). Beijing, China.

These authors contributed equally to this work

Abstract

The Sequencing reads of this study are derived from research shared by Aaron J. Wilk. We conducted a deep analysis of B lymphocyte data. A total of 2126 differentially expressed genes were listed out. Through GO enrichment analysis, 24 clusters related to B lymphocyte functioning were screened out, and genes with significant differential expression were mainly enriched in 10 KEGG signaling pathways related to immune regulatory functions. This suggests that there are differences in the expression of immune regulatory genes in the immune process of B lymphocytes during the Sars-Cov2 infection.

Keywords

COVID-19, B lymphocytes, expression difference

Cite This Paper

Kehan Lin, Hengxi Liu, Junying Li, Chenhao Shou, Yihan Xia, Ming Chu, Xi Chen. Differential gene expression in B lymphocyte immune process induced by COVID-19 infection. Frontiers in Medical Science Research (2021) Vol. 3 Issue 6: 1-5. https://doi.org/10.25236/FMSR.2021.030601.

References

[1] Berthelot JM;Lioté F;Maugars Y;Sibilia J. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING, Frontiers in immunology,2020, 11,607069.

[2] Meshcheryakova A;Pietschmann P;Zimmermann P;Rogozin IB;Mechtcheriakova D.AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19, Frontiers in immunology,2021,12,690416.

[3] You M;Chen L;Zhang D;Zhao P;Chen Z;Qin EQ;Gao Y;Davis MM;Yang P.Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19,Nature cell biology,2021,23,620-630.

[4] Cheema PS;Nandi D;Nag A.Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19,Open biology,2021,11,210069.

[5] Zhao J;Jaffe A;Li H;Lindenbaum O;Sefik E;Jackson R;Cheng X;Flavell RA;Kluger Y.Detection of differentially abundant cell subpopulations in scRNA-seq data,Proceedings of the National Academy of Sciences of the United States of America,2021,118,22.

[6] Liang C;Bencurova E;Psota E;Neurgaonkar P;Prelog M;Scheller C;Dandekar T. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries,International journal of molecular sciences,2021,22.